Medreich Limited Erythromycin Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Erythromycin Export Records India — #5 Exporter, 96 Shipments, $2.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Erythromycin

India Pharmaceutical Trade Intelligence

$79.7M368 Suppliers135 CountriesHS 30042061

ExportsIndia → AFGHANISTAN28.8%India → PHILIPPINES14.3%

ImportsBULGARIA → India$3.6M UNITED STATES → India$337.8K

#1 Supplier: MEDOPHARM

Medreich Limited — Erythromycin Exporter #5 | $2.1M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Erythromycin Exporter Profile

Indian Pharmaceutical Exporter · #5 for Erythromycin · $2.1M export value · DGFT Verified

Medreich Limited is the #5 Indian exporter of Erythromycin with $2.1M in export value and 96 verified shipments. Medreich Limited holds a 2.7% market share in Erythromycin exports across 4 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Erythromycin Export Profile: Buyers & Destinations

Medreich Limited Erythromycin export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Erythromycin?

Country	Value	Shipments	Share
AUSTRALIA	$1.0M	54	52.6%
NEW ZEALAND	$818.4K	38	41.9%
YEMEN, DEMOCRATIC	$52.5K	2	2.7%
UNITED KINGDOM	$29.9K	1	1.5%
YEMEN	$24.8K	1

Who Are the Top Buyers of Erythromycin from Medreich Limited?

Buyer	Country	Value	Orders
MYLAN AUSTRALIA PTY LIMITED	AUSTRALIA	$1.0M	54
VIATRIS NEW ZEALAND	NEW ZEALAND	$771.1K	33
AL-JABER PHARMA FOR DRUGS&MEDICAL	YEMEN, DEMOCRATIC	$52.5K	2
MYLAN NEW ZEALAND LTD	NEW ZEALAND	$47.2K	5
MEDREICH PLC	UNITED KINGDOM	$29.9K	1
AL-JABAR PHARMA FOR DRUGS & MEDICAL	YEMEN	$24.8K	1

Medreich Limited supplies Erythromycin to 6 buyers globally. The largest buyer is MYLAN AUSTRALIA PTY LIMITED (AUSTRALIA), followed by VIATRIS NEW ZEALAND (NEW ZEALAND) and AL-JABER PHARMA FOR DRUGS&MEDICAL (YEMEN, DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Erythromycin Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR O	$243.3K	17
ERYTHROMYCIN ETHYLSUCCCINATE TABLETS 400	$200.0K	4
ERYTHROMYCIN ETHYLSUCCCINATE POWDER FOR	$142.9K	12
E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TAB	$105.7K	3
ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400M	$100.0K	2
E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG) 25S (52320 PACKS)	$92.4K	3
ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG (E-MYCIN) 100S (6744 PACKS)	$62.3K	3
ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400mg E-MYCIN 100S 6840 PACKS	$50.0K	1
ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG (E-MYCIN) 100S (6840 PACKS)	$50.0K	1
ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400mg (E-MYCIN) 100S(6624 PACKS)	$50.0K	1

Medreich Limited exports 52 distinct Erythromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR O with 17 shipments worth $243.3K.

How Does Medreich Limited Compare to Nearest Erythromycin Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MEDOPHARM	$3.0M	61	14	$50.0K
4	S KANT HEALTHCARE LIMITED	$2.8M	94	20	$29.9K
5	MEDREICH LIMITED ★	$2.1M	96	4	$22.1K
6	CADILA PHARMACEUTICALS LIMITED	$1.4M	69	5	$20.8K
7	BHARAT PARENTERALS LIMITED	$1.4M	37	2	$36.6K

Medreich Limited ranks #5 among 368 Indian Erythromycin exporters. Average shipment value of $22.1K compared to the market average of $51.7K. The closest competitors by value are MEDOPHARM and S KANT HEALTHCARE LIMITED.

Which Indian Ports Ship Erythromycin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	513	13.0%
DELHI AIR CARGO ACC (INDEL4)	394	10.0%
SAHAR AIR	377	9.6%
NHAVA SHEVA SEA (INNSA1)	370	9.4%
JNPT/ NHAVA SHEVA SEA	234	5.9%
DELHI AIR	227	5.8%
JNPT	176	4.5%
Bombay Air	99	2.5%

Geopolitical & Trade Policy Impact on Medreich Limited's Erythromycin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 96 individual customs records matching Medreich Limited exporting Erythromycin, covering 52 formulations to 5 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 135+ countries, 992+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Erythromycin

Erythromycin

Medreich Limited — Erythromycin Exporter Profile

Medreich Limited — Erythromycin Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Erythromycin?

Who Are the Top Buyers of Erythromycin from Medreich Limited?

What Is India's Total Erythromycin Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Erythromycin Exports?

How Does Medreich Limited Compare to Other Indian Erythromycin Exporters?

What Erythromycin Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Erythromycin to Key Markets

Australia — TGA

How Does Medreich Limited Compare to Nearest Erythromycin Exporters?

Which Indian Ports Ship Erythromycin Exports?

What Other Antibiotics Products Does Medreich Limited Export?

Erythromycin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Medreich Limited's Erythromycin Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Erythromycin Export Data from Medreich Limited

Erythromycin Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source